A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma

Clinical trial NCT04625205 · TERMINATED

Trial details

NCT number: NCT04625205
Sponsor: BioNTech US Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable Melanoma Metastatic Melanoma

Start date: 2020-12-01
Primary completion: 2025-03-26
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.